6.99
3.71%
0.25
Handel nachbörslich:
6.91
-0.08
-1.14%
Schlusskurs vom Vortag:
$6.74
Offen:
$6.735
24-Stunden-Volumen:
413.83K
Relative Volume:
0.87
Marktkapitalisierung:
$278.31M
Einnahmen:
$324.01M
Nettoeinkommen (Verlust:
$-192.37M
KGV:
43.69
EPS:
0.16
Netto-Cashflow:
$-23.46M
1W Leistung:
+0.72%
1M Leistung:
+14.59%
6M Leistung:
+11.48%
1J Leistung:
+2.64%
Angiodynamic Inc Stock (ANGO) Company Profile
Firmenname
Angiodynamic Inc
Sektor
Telefon
(518) 798-1215
Adresse
14 PLAZA DRIVE, LATHAM
Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-04-05 | Hochstufung | Oppenheimer | Perform → Outperform |
2023-09-25 | Eingeleitet | H.C. Wainwright | Buy |
2023-04-17 | Herabstufung | Raymond James | Strong Buy → Outperform |
2021-10-15 | Hochstufung | Canaccord Genuity | Hold → Buy |
2021-08-20 | Eingeleitet | Oppenheimer | Perform |
2020-11-25 | Hochstufung | Raymond James | Mkt Perform → Strong Buy |
2020-04-08 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
2019-04-01 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
2018-04-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
2018-01-05 | Herabstufung | Craig Hallum | Buy → Hold |
2017-04-07 | Bestätigt | Cantor Fitzgerald | Overweight |
2017-03-30 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
2017-02-08 | Eingeleitet | Barclays | Equal Weight |
2016-11-04 | Eingeleitet | Cantor Fitzgerald | Buy |
2016-04-08 | Fortgesetzt | Piper Jaffray | Neutral |
2016-01-08 | Bestätigt | Canaccord Genuity | Buy |
2015-11-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
2015-07-24 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
2014-06-19 | Hochstufung | Canaccord Genuity | Hold → Buy |
2012-10-09 | Bestätigt | Canaccord Genuity | Hold |
2012-06-25 | Herabstufung | Canaccord Genuity | Buy → Hold |
2011-07-15 | Hochstufung | Canaccord Genuity | Hold → Buy |
2011-07-15 | Hochstufung | Stifel Nicolaus | Hold → Buy |
2011-06-14 | Herabstufung | Wedbush | Neutral → Underperform |
2010-09-08 | Bestätigt | Wedbush | Neutral |
Alle ansehen
Angiodynamic Inc Aktie (ANGO) Neueste Nachrichten
AngioDynamics Stock Plunges 13.8% in Three Months: What's Next? - MSN
AngioDynamics staying in Queensbury after all. Leaders cite changed business model. - The Post Star
SG Americas Securities LLC Invests $103,000 in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
Short Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Rises By 31.0% - MarketBeat
Cwm LLC Raises Stock Position in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
Zacks Research Lowers Earnings Estimates for AngioDynamics - Defense World
Here's Why You Should Add AngioDynamics Stock to Your Portfolio - MSN
AngioDynamics (NASDAQ:ANGO) Stock Price Passes Above 200-Day Moving Average – Should You Sell? - Defense World
AngioDynamics’ NanoKnife System gains CPT codes for prostate and liver treatments - Yahoo! Voices
AngioDynamics Announces American Medical Association’s CPT® Editorial Panel Grants Category I CPT® for Irreversible Electroporation (IRE) in Prostate and Liver - StockTitan
Angiodynamic Inc (ANGO)’s stock decline to 6.33 per share - US Post News
Its Stock Has Paid Off Big Time For Angiodynamic Inc - SETE News
Angel One Profits Jump 39% Thanks To Trading Boom - Finimize
A Guide To The Risks Of Investing In Angiodynamic Inc (ANGO) - Knox Daily
AngioDynamics, Inc. (NASDAQ:ANGO) Sees Significant Decrease in Short Interest - MarketBeat
Insider Buying: Nighan Warren JR, Angiodynamic Inc [ANGO] SVP Quality and Regulatory invested 768 shares - Knox Daily
Study Begins For AngioDynamics' AlphaVac F18⁸⁵ System - MPO-mag
Perrigo Company plc [PRGO] Records 50-Day SMA of $27.19 - Knox Daily
Marshall Wace LLP Sells 218,500 Shares of AngioDynamics, Inc. (NASDAQ:ANGO) - MarketBeat
AQR Capital Management LLC Sells 95,983 Shares of AngioDynamics, Inc. (NASDAQ:ANGO) - MarketBeat
Mackenzie Financial Corp Acquires Shares of 13,270 AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
3 Stocks Insiders Are Buying Heavily in October and Why - Investing.com
The Angiodynamic Inc (ANGO) had a good session last reading, didn’t it? - US Post News
Dimensional Fund Advisors LP Sells 242,478 Shares of AngioDynamics, Inc. (NASDAQ:ANGO) - MarketBeat
James C. Clemmer Buys 20,000 Shares of AngioDynamics, Inc. (NASDAQ:ANGO) Stock - MarketBeat
AngioDynamics CFO acquires $9.96k in company stock - Investing.com
AngioDynamics, Inc. (NASDAQ:ANGO) Shares Sold by Williams & Novak LLC - Defense World
Check out these key findings about Angiodynamic Inc (ANGO) - SETE News
Analysts review Angiodynamic Inc’s rating - Knox Daily
Deeper Dive: Understanding Angiodynamic Inc (ANGO) Through its Various Ratios - The Dwinnex
Annaly Capital Management Inc [NLY] Insider Finkelstein David L sells 50,000 Shares - Knox Daily
Millennium Management LLC Raises Position in AngioDynamics, Inc. (NASDAQ:ANGO) - MarketBeat
Angiodynamic Inc (ANGO) Stock: Navigating Drops and Gains - The InvestChronicle
AngioDynamics slides after Q1 revenue miss - MSN
Angiodynamic Inc [ANGO] Shares Fall -16.73 % on Thursday - Knox Daily
AngioDynamics, Inc. (NASDAQ:ANGO) Misses Revenue Estimates - FXDailyReport.com
AngioDynamics Stock Up on Q1 Earnings Beat, Y/Y Pro-Forma Sales Rise - Yahoo Finance
Prepare Yourself for Liftoff: Angiodynamic Inc (ANGO) - SETE News
AngioDynamics, Inc. (NASDAQ:ANGO) Q1 2025 Earnings Call Transcript - Insider Monkey
AngioDynamics, Inc. (NASDAQ:ANGO): Are Analysts Optimistic? - Simply Wall St
AngioDynamics Sees Growth Amidst Challenges in Fiscal 2025 - Yahoo Finance
Market Momentum: Angiodynamic Inc (ANGO) Registers a -16.73 Decrease, Closing at 6.37 - The Dwinnex
NVIDIA Corp [NASDAQ: NVDA] Sees Increase in Stock Value - Knox Daily
Director MILLER JAMES H sale 1,006 shares of Crown Holdings, Inc. [CCK] - Knox Daily
AngioDynamics Inc (ANGO) Q1 2025 Earnings Call Transcript Highli - GuruFocus.com
AngioDynamics Inc (ANGO) Q1 2025 Earnings Call Transcript Highlights: A Promising Start with ... - Yahoo Finance
AngioDynamics stock slides on Q1 revenue miss (NASDAQ:ANGO) - Seeking Alpha
AngioDynamics Shares Tumble as Company Swings to 1Q Loss - MarketWatch
ANGO’s 2023 Market Dance: Down -20.15% – Time to Invest? - The InvestChronicle
ANGO’s price-to-free cash flow ratio: What it means for investors - US Post News
General Motors Company (NYSE: GM) Down -0.54%: This Is What Analysts Are Now Forecasting - Stocks Register
Finanzdaten der Angiodynamic Inc-Aktie (ANGO)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):